2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine

C92H90F12N18 — CID 157392101

IUPAC2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine
SMILESCc1cc(Nc2cc(-c3ccccc3C(F)(F)F)nc(C3CCCCC3)c2)n[nH]1.Cc1cc(Nc2cc(-c3ccccc3C(F)(F)F)nc(C3CCNCC3)c2)n[nH]1.FC(F)(F)c1ccccc1-c1cc(Nc2n[nH]c3ccccc23)cc(C2CCCCC2)n1.FC(F)(F)c1ccccc1-c1cc(Nc2n[nH]c3ccccc23)cc(C2CCNCC2)n1
InChIInChI=1S/C25H23F3N4.C24H22F3N5.C22H23F3N4.C21H22F3N5/c26-25(27,28)20-12-6-4-10-18(20)23-15-17(14-22(30-23)16-8-2-1-3-9-16)29-24-19-11-5-7-13-21(19)31-32-24;25-24(26,27)19-7-3-1-5-17(19)22-14-16(13-21(30-22)15-9-11-28-12-10-15)29-23-18-6-2-4-8-20(18)31-32-23;1-14-11-21(29-28-14)26-16-12-19(15-7-3-2-4-8-15)27-20(13-16)17-9-5-6-10-18(17)22(23,24)25;1-13-10-20(29-28-13)26-15-11-18(14-6-8-25-9-7-14)27-19(12-15)16-4-2-3-5-17(16)21(22,23)24/h4-7,10-16H,1-3,8-9H2,(H2,29,30,31,32);1-8,13-15,28H,9-12H2,(H2,29,30,31,32);5-6,9-13,15H,2-4,7-8H2,1H3,(H2,26,27,28,29);2-5,10-12,14,25H,6-9H2,1H3,(H2,26,27,28,29)
InChIKeyBMDABNJZZPDSNV-UHFFFAOYSA-N
MW1675.83 g/mol
LogP24.89
Rot. Bonds16

About 2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine

2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine (PubChem CID 157392101) has the molecular formula C92H90F12N18 and a molecular weight of 1675.83 g/mol. Its IUPAC name is 2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine.

Molecular Properties

Compound Name2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine
PubChem CID157392101
Molecular FormulaC92H90F12N18
Molecular Weight1675.83 g/mol
Exact Mass1674.74
IUPAC Name2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine
SMILESCc1cc(Nc2cc(-c3ccccc3C(F)(F)F)nc(C3CCCCC3)c2)n[nH]1.Cc1cc(Nc2cc(-c3ccccc3C(F)(F)F)nc(C3CCNCC3)c2)n[nH]1.FC(F)(F)c1ccccc1-c1cc(Nc2n[nH]c3ccccc23)cc(C2CCCCC2)n1.FC(F)(F)c1ccccc1-c1cc(Nc2n[nH]c3ccccc23)cc(C2CCNCC2)n1
InChIInChI=1S/C25H23F3N4.C24H22F3N5.C22H23F3N4.C21H22F3N5/c26-25(27,28)20-12-6-4-10-18(20)23-15-17(14-22(30-23)16-8-2-1-3-9-16)29-24-19-11-5-7-13-21(19)31-32-24;25-24(26,27)19-7-3-1-5-17(19)22-14-16(13-21(30-22)15-9-11-28-12-10-15)29-23-18-6-2-4-8-20(18)31-32-23;1-14-11-21(29-28-14)26-16-12-19(15-7-3-2-4-8-15)27-20(13-16)17-9-5-6-10-18(17)22(23,24)25;1-13-10-20(29-28-13)26-15-11-18(14-6-8-25-9-7-14)27-19(12-15)16-4-2-3-5-17(16)21(22,23)24/h4-7,10-16H,1-3,8-9H2,(H2,29,30,31,32);1-8,13-15,28H,9-12H2,(H2,29,30,31,32);5-6,9-13,15H,2-4,7-8H2,1H3,(H2,26,27,28,29);2-5,10-12,14,25H,6-9H2,1H3,(H2,26,27,28,29)
InChIKeyBMDABNJZZPDSNV-UHFFFAOYSA-N
XLogP24.89
TPSA238.46 Ų
H-Bond Donors10
H-Bond Acceptors14
Rotatable Bonds16
Heavy Atoms122
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001675.83
LogP ≤ 524.89
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1014

Analyze 2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine?
The IUPAC name of 2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine (CID 157392101) is 2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine.
What is the SMILES notation for 2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine?
The canonical SMILES for 2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine is Cc1cc(Nc2cc(-c3ccccc3C(F)(F)F)nc(C3CCCCC3)c2)n[nH]1.Cc1cc(Nc2cc(-c3ccccc3C(F)(F)F)nc(C3CCNCC3)c2)n[nH]1.FC(F)(F)c1ccccc1-c1cc(Nc2n[nH]c3ccccc23)cc(C2CCCCC2)n1.FC(F)(F)c1ccccc1-c1cc(Nc2n[nH]c3ccccc23)cc(C2CCNCC2)n1.
What is the InChIKey of 2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine?
The InChIKey is BMDABNJZZPDSNV-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H23F3N4.C24H22F3N5.C22H23F3N4.C21H22F3N5/c26-25(27,28)20-12-6-4-10-18(20)23-15-17(14-22(30-23)16-8-2-1-3-9-16)29-24-19-11-5-7-13-21(19)31-32-24;25-24(26,27)19-7-3-1-5-17(19)22-14-16(13-21(30-22)15-9-11-28-12-10-15)29-23-18-6-2-4-8-20(18)31-32-23;1-14-11-21(29-28-14)26-16-12-19(15-7-3-2-4-8-15)27-20(13-16)17-9-5-6-10-18(17)22(23,24)25;1-13-10-20(29-28-13)26-15-11-18(14-6-8-25-9-7-14)27-19(12-15)16-4-2-3-5-17(16)21(22,23)24/h4-7,10-16H,1-3,8-9H2,(H2,29,30,31,32);1-8,13-15,28H,9-12H2,(H2,29,30,31,32);5-6,9-13,15H,2-4,7-8H2,1H3,(H2,26,27,28,29);2-5,10-12,14,25H,6-9H2,1H3,(H2,26,27,28,29).
What are the key properties of 2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine?
2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine has a molecular weight of 1675.83 g/mol, XLogP of 24.89, 16 rotatable bonds, 10 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclohexyl-N-(5-methyl-1H-pyrazol-3-yl)-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-cyclohexyl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]pyridin-4-amine;N-[2-piperidin-4-yl-6-[2-(trifluoromethyl)phenyl]-4-pyridinyl]-1H-indazol-3-amine is sourced from PubChem (CID 157392101), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).